| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |